1 477

Cited 7 times in

Secretory carcinoma of breast demonstrates nuclear or cytoplasmic expression in p63 immunohistochemistry

DC Field Value Language
dc.contributor.author구자승-
dc.date.accessioned2014-12-19T16:58:41Z-
dc.date.available2014-12-19T16:58:41Z-
dc.date.issued2012-
dc.identifier.issn1066-8969-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/90550-
dc.description.abstractThe aim of this study was to evaluate the pattern of p63 expression and its implication in secretory carcinoma of the breast. Immunohistochemical staining for p63, p53, MDM2, and smooth muscle actin was performed in 7 cases of secretory carcinomas. Nuclear expression of p63 was observed in 3 cases, whereas staining against cytoplasmic and intraluminal secretory material were observed in 4 cases. p53 was expressed in 3 cases and MDM2 in 2 cases. The loss of myoepithelial cells was confirmed by immunohistochemical stain for smooth muscle actin in invasive secretory carcinomas. The pattern of expression of p63 in secretory carcinoma of the breast was revealed in nuclei or cytoplasm/secretory materials.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHBiomarkers, Tumor/metabolism-
dc.subject.MESHBreast Neoplasms/metabolism*-
dc.subject.MESHBreast Neoplasms/pathology-
dc.subject.MESHBreast Neoplasms/secondary-
dc.subject.MESHCarcinoma/metabolism*-
dc.subject.MESHCarcinoma/secondary-
dc.subject.MESHCell Nucleus/metabolism*-
dc.subject.MESHCell Nucleus/pathology-
dc.subject.MESHCytoplasm/metabolism*-
dc.subject.MESHCytoplasm/pathology-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHLymph Nodes/pathology-
dc.subject.MESHLymphatic Metastasis-
dc.subject.MESHMiddle Aged-
dc.subject.MESHTranscription Factors/metabolism*-
dc.subject.MESHTumor Suppressor Proteins/metabolism*-
dc.titleSecretory carcinoma of breast demonstrates nuclear or cytoplasmic expression in p63 immunohistochemistry-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학)-
dc.contributor.googleauthorJunjeong Choi-
dc.contributor.googleauthorDokyung Kim-
dc.contributor.googleauthorJa Seung Koo-
dc.identifier.doi10.1177/1066896912440506-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00198-
dc.relation.journalcodeJ01164-
dc.identifier.eissn1940-2465-
dc.identifier.pmid22491513-
dc.identifier.urlhttp://ijs.sagepub.com/content/20/4/367-
dc.subject.keywordbreast-
dc.subject.keywordsecretory carcinoma-
dc.subject.keywordp63-
dc.contributor.alternativeNameKoo, Ja Seung-
dc.contributor.affiliatedAuthorKoo, Ja Seung-
dc.contributor.affiliatedAuthor구자승-
dc.citation.volume20-
dc.citation.number4-
dc.citation.startPage367-
dc.citation.endPage372-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, Vol.20(4) : 367-372, 2012-
dc.identifier.rimsid32828-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.